Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hamann

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffoldLawrence G Hamann, J Hoyt Meyer, Daniel A Ruppar, et al.
The Journal of Clinical Psychiatry|October 1, 1988
Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramineB G Wells, R L Evans, L Ereshefsky, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonistsL G Hamann, L J Farmer, M G Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2014
Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disordersDavid S Yoon, Shung C Wu, Ramakrishna Seethala, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic ModalityPhilip P Chamberlain, Laura A D'Agostino, J Michael Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitorsStephen P O'Connor, Ying Wang, Ligaya M Simpkins, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)Haixia Wang, Jeffrey A Robl, Lawrence G Hamann, et al.
Chemical Science|February 17, 2015
Non-Directed Allylic C-H Acetoxylation in the Presence of Lewis Basic HeterocyclesHasnain A Malik, Buck L H Taylor, John R Kerrigan, et al.
Journal of Medicinal Chemistry|April 26, 1996
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl etherL G Hamann, L J Farmer, M G Johnson, et al.
Journal of Medicinal Chemistry|March 4, 1998
Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolinesL G Hamann, R I Higuchi, L Zhi, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffoldLawrence G Hamann, J Hoyt Meyer, Daniel A Ruppar, et al.
The Journal of Clinical Psychiatry|October 1, 1988
Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramineB G Wells, R L Evans, L Ereshefsky, et al.
Annals of the New York Academy of Sciences|June 12, 1995
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonistsL G Hamann, L J Farmer, M G Johnson, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2014
Discovery of pyridyl sulfonamide 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors for the treatment of metabolic disordersDavid S Yoon, Shung C Wu, Ramakrishna Seethala, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic ModalityPhilip P Chamberlain, Laura A D'Agostino, J Michael Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2010
Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitorsStephen P O'Connor, Ying Wang, Ligaya M Simpkins, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2011
Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)Haixia Wang, Jeffrey A Robl, Lawrence G Hamann, et al.
Chemical Science|February 17, 2015
Non-Directed Allylic C-H Acetoxylation in the Presence of Lewis Basic HeterocyclesHasnain A Malik, Buck L H Taylor, John R Kerrigan, et al.
Journal of Medicinal Chemistry|April 26, 1996
Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl etherL G Hamann, L J Farmer, M G Johnson, et al.
Journal of Medicinal Chemistry|March 4, 1998
Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolinesL G Hamann, R I Higuchi, L Zhi, et al.
Pageof 12